Company Analysis Biocon Limited
1. Summary
Advantages
- The stock's return over the last year (36.24%) is higher than the sector average (10.49%).
Disadvantages
- Price (365.2 βΉ) is higher than fair price (104.68 βΉ)
- Dividends (0.4194%) are below the sector average (9.57%).
- Current debt level 29.03% has increased over 5 years from 19.74%.
- The company's current efficiency (ROE=5.43%) is lower than the sector average (ROE=10.72%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Biocon Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.3% | -1.5% | 3.5% |
| 90 days | 8.2% | -10.5% | -2.2% |
| 1 year | 36.2% | 10.5% | 9% |
BIOCON vs Sector: Biocon Limited has outperformed the "Healthcare" sector by 25.75% over the past year.
BIOCON vs Market: Biocon Limited has outperformed the market by 27.22% over the past year.
Stable price: BIOCON is not significantly more volatile than the rest of the market on "National Stock Exchange Of India" over the last 3 months, with typical variations of +/- 5% per week.
Long period: BIOCON with weekly volatility of 0.6968% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (365.2 βΉ) is higher than the fair price (104.68 βΉ).
Price is higher than fair: The current price (365.2 βΉ) is 71.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (29.52) is lower than that of the sector as a whole (59.63).
P/E vs Market: The company's P/E (29.52) is lower than that of the market as a whole (65.53).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.19) is lower than that of the sector as a whole (6.64).
P/BV vs Market: The company's P/BV (1.19) is lower than that of the market as a whole (6.53).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.05) is lower than that of the sector as a whole (9.32).
P/S vs Market: The company's P/S indicator (2.05) is lower than that of the market as a whole (18.85).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (10.89) is lower than that of the sector as a whole (141.59).
EV/Ebitda vs Market: The company's EV/Ebitda (10.89) is lower than that of the market as a whole (25.16).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 7.33% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (7.33%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-3.2%).
5.4. ROE
ROE vs Sector: The company's ROE (5.43%) is lower than that of the sector as a whole (10.72%).
ROE vs Market: The company's ROE (5.43%) is higher than that of the market as a whole (3.59%).
5.5. ROA
ROA vs Sector: The company's ROA (1.89%) is lower than that of the sector as a whole (7.64%).
ROA vs Market: The company's ROA (1.89%) is lower than that of the market as a whole (7.91%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (1.86%) is lower than that of the sector as a whole (15.91%).
ROIC vs Market: The company's ROIC (1.86%) is lower than that of the market as a whole (15.54%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.4194% is below the average for the sector '9.57%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.4194% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 0.4194% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (19.85%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
